Frequency of Cysts by Immunofluorescence Assay in Human Brain Tissue of Suicide, Traffic Accident and Homicide Decedents

Authors

  • Karol J. Isaza Five-year Medical Student, University of Quindío, Armenia, Colombia.
  • Santiago Guerrero V Five-year Medical Student, University of Quindío, Armenia, Colombia.
  • Laura M. García G Five-year Medical Student, University of Quindío, Armenia, Colombia.
  • Jennifer Nessim Psychologist. PhD student, University of Quindío, Armenia, Colombia.
  • Miguel Baquero MD, Pathologist, of the National Institute of Legal Medicine and Forensic Sciences, Armenia, Colombia.
  • Jorge E. Gomez M MD. PhD Professor, University of Quindio, Armenia, Colombia.

DOI:

https://doi.org/10.5195/ijms.2023.2356

Keywords:

Fluorescent Antibody Technique, BAG1 Antigen, Human Brain, Violent Death

Abstract

BACKGROUND: Several studies link toxoplasmosis with neuropsychiatric disorders. There are no previous reports of the frequency of the presence of parasite tissue cysts in autopsy cases from violent death or how is the distribution of frequency according to brain regions related with behavior (amygdala or hippocampus). The immune fluorescent antibody technique (IFAT) detects specific target antigens that allow the observation of bradyzoites within tissue cysts. We describe the frequency of tissue cysts using the IFAT detection in human brain tissue samples from immunocompetent persons deceased by suicide, traffic accidents and homicide.

METHODS: 21 brains from the National Institute of Legal Medicine and Forensic Sciences chapter “Eje Cafetero” (including cities of Armenia, Pereira, and Manizales) of violently deceased (which includes suicide, traffic accidents and homicide) persons were obtained, subsequently sections of the amygdala and hippocampus areas were processed in paraffin and thick sections were cut from paraffin blocks and mounted on slides by means of the IFAT, by using specific monoclonal anti BAG1 protein of the bradyzoite. Serum samples from the decedents were also examined for the presence of IgG and IgM antibodies to establish the existence of a previous infection. Data such as age, gender, sociodemographic data, and type of death were also obtained. Evaluation of the differences in the percentage of positivity according to the cause of death were assayed by using the Fisher exact test.

RESULTS: Two decedents (9.5%) were female and 19 (90.4%) were male. The age ranged from 14 to 65 years; most completed or were in high school level of education. By city, 9 were from Armenia (42.8%%) and 12 from Manizales (57.1%). By type of death, 11 samples (52.3%) were victims of homicide, 9 samples (42.8%) were suicide, and one sample (4.7%) was a traffic accident. We identified tissue cysts containing the bradyzoites in two cases in amygdala (9.5%), in amygdala and hippocampus in tree (14.2%), and one case only in hippocampus (4.7%). In total we have six of 23 (26%) were positive for cysts in the brain. No statistically significant differences were found between groups in the percent of positivity. After counting we found a mean 1,3 ± 0,4 cysts by 20 microscopy fields of positive brain tissue examined. We found one of 21 positives for IgG antibodies in blood (47%). Within six cases with positive by IFAT in brain tissue five were also positive in antibodies (83%) only one case was negative for antibodies.

CONCLUSION: The presence of bradyzoite was demonstrated in brain tissue samples from immunocompetent patients who suffered a violent death in the cities of Armenia and Manizales, Colombia. The results suggest that the bradyzoite after infection is permanently localized in brain tissue. A higher prevalence of bradyzoite parasites is observed in amygdala samples, an important region for behavior control.

Metrics

Metrics Loading ...

References

Alvarado-Esquivel C, Sánchez-Anguiano LF, Mendoza-Larios A, Hernández-Tinoco J, Pérez-Ochoa JF, Antuna-Salcido EI, et al. Prevalence of Toxoplasma gondii infection in brain and heart by Immunohistochemistry in a hospital-based autopsy series in Durango, Mexico. Eur J Microbiol Immunol 2015;5(2):149. http://dx.doi.org/10.1556/1886.2015.00014

Mahittikorn A, Wickert H, Sukthana Y. Toxoplasma gondii: Simple duplex RT-PCR assay for detecting SAG1 and BAG1 genes during stage conversion in immunosuppressed mice. Exp Parasitol [Internet]. 2010;124(2):225–31. Disponible en: http://dx.doi.org/10.1016/j.exppara.2009.10.003

Mendoza-Larios LA, García-Dolores F, Sánchez-Anguiano LF, Hernández-Tinoco J, Alvarado-Esquivel C. Association between suicide and Toxoplasma gondii seropositivity. Pathogens [Internet]. 2021;10(9):1094. Disponible en: http://dx.doi.org/10.3390/pathogens10091094

Downloads

Published

2023-12-19

How to Cite

Isaza, K. J., Guerrero V, S., García G, L. M., Nessim, J., Baquero, M., & Gomez M, J. E. (2023). Frequency of Cysts by Immunofluorescence Assay in Human Brain Tissue of Suicide, Traffic Accident and Homicide Decedents. International Journal of Medical Students, 11, S65. https://doi.org/10.5195/ijms.2023.2356

Issue

Vol 11. (2023): Supplement 1

Section

Abstracts of the WCMSR

Categories

License

Copyright (c) 2023 Karol J. Isaza, Santiago Guerrero V, Laura M. García G, Jennifer Nessim, Miguel Baquero, Jorge E. Gomez M

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org

Most read articles by the same author(s)